GE biopharma sale could surface more health care value: Expert

In this video

Share

GE biopharma sale could surface more health care value: Expert

GE after biopharma sale with Justin Bergner, senior analyst at Gabelli & Co
03:45
Mon, Feb 25 20192:36 PM EST